fda shortage semaglutide injection products resolved feb 21 2025 Declares of Novo Nordisk's Wegovy, Ozempic Over Semaglutide Injections and the FDA

The early effects may be subtle, especially if youre on a lower starting dose

Today's #JACCJournals featured trial in the #Obesity Revolution is the FLOW trial

Retatrutide remains in phase 3 clinical development (the TRIUMPH program)

Here are some points to cover: When symptoms began : Knowing when the constipation or digestive issue started is helpful

Oftentimes, they ask for confirmation that the patient has tried diet and exercise previously or plans to continue lifestyle therapies along with the anti-obesity medication, and some prior authorizations will ask for a list of prior anti-obesity medications that have been tried. Of the BCBS plans we reviewed that covered Wegovy, all required prior authorization

How Pharmacists Ensure Compliance Through Certificates Of Analysis (COAs) A Certificate of Analysis (COA) is a critical document that a pharmacist uses to verify the quality of the active ingredient they purchase from a supplier